Farsund T
Virchows Arch B Cell Pathol. 1978 Feb 14;26(4):369-73.
A dose of 2 mg cyclophosphamide (Sendoxan, "Pharamcia", Sweden) dissolved in 0.2 ml distilled water was injected intraperitoneally once a week to 12 hairless mice for three months. Four animals were killed at 1, 2 and 3 months and micro-flow fluormetric histograms of the bladder epithelial cells were made. The proportion of cells in diploid S phase remained normal at 1 and 2 months, but increased at 3 months. The proportion of tetraploid S-phase cells fell rapidly and markedly and there were almost no cells in this phase at 1, 2 and 3 months. The proportion of diploid cells increased, the proportion of tetraploids was significantly reduced and the octoploid cells disappeared after 2 months. The changes are similar to those seen after repeated injections of the bladder carcinogen dibutylnitrosamine, but less pronounced. Since cyclophosphamide is a strong alkylating agent it is possible that, in the doses used, it is also a weak carcinogen for hte bladder epithelium. This must be tested in direct, long-term treatment experiments. Bladder cancers in humans receiving cyclophosphamide therapy have been described.
将2毫克环磷酰胺(环磷酰胺,“法玛西亚”,瑞典)溶于0.2毫升蒸馏水中,每周一次对12只无毛小鼠进行腹腔注射,持续三个月。在第1、2和3个月时处死4只动物,并制作膀胱上皮细胞的微流式荧光直方图。二倍体S期细胞的比例在1个月和2个月时保持正常,但在3个月时增加。四倍体S期细胞的比例迅速且显著下降,在1、2和3个月时该阶段几乎没有细胞。二倍体细胞的比例增加,四倍体的比例显著降低,八倍体细胞在2个月后消失。这些变化与反复注射膀胱致癌物二丁基亚硝胺后观察到的变化相似,但不太明显。由于环磷酰胺是一种强烷化剂,在所使用的剂量下,它也有可能是膀胱上皮的一种弱致癌物。这必须在直接的长期治疗实验中进行测试。已有接受环磷酰胺治疗的人类膀胱癌的相关描述。